Branchio-oculo-facial syndrome
Branchio-oculo-facial syndrome | |
---|---|
Other names | Hemangiomatous branchial clefts-lip pseudocleft syndrome |
Autosomal dominant is the manner of inheritance of this condition |
Branchio-oculo-facial syndrome (BOFS)
Signs and symptoms
"Branchio" refers to the
Pathophysiology
The disease is genetically inherited and stems from a mutation that deletes the TFAP2A gene. This gene is important because it provides the blueprint for the arrangement of 437 amino acids that make up the protein transcription factor known as AP-2 alpha. This protein transcription factor binds to a carboxy terminus helix-span-helix motif and an amino terminus portion of DNA that affects the activity of numerous cellular activities such as cell division and apoptosis.[clarification needed] AP-2 alpha is especially important during the embryos development principally in the development of the branchial arches. Currently there are also four other proteins that are affected by the deletion of TFAP2A gene as well. One is L249P, this protein changes to cause a conformational space change with a substituted proline. Furthermore, a change in the R254W and R255G proteins results in a replacement of a charged polar side chain by a nonpolar side chain,[clarification needed] and lastly, an alteration in the G262E protein results in a nonpolar side chain being replaced by a charged polar side chain.[1]
Diagnosis
Branchio-oculo-facial syndrome is difficult to diagnose because it has
Management
The care and management of people with BOFS is aimed at the specific signs and symptoms, and should be carried out by a multi-specialty team who are skilled in craniofacial disorders. A medical geneticist usually makes the clinical diagnosis, which is confirmed with molecular testing. Reconstructive surgery is needed to repair facial deformities and obstructed nasal ducts. Importantly, the skin defects should not be treated with simple cauterization. Strabismus ("crossed eyes") may be corrected by surgery.
In addition, people with BOFS should be managed by an ophthalmologist, otolaryngologist, dentist, and speech therapist. Depending on the person's issues, there may be a need for a neuropsychologic or developmental evaluation and mental health support.
Genetic counseling is recommended for the patients and their families for reproductive health. [4]
Epidemiology
It was estimated that only 100 cases of BOFS have been documented in the medical literature as of 2018[update] .[4]
References
- ^ PMID 18423521.
- S2CID 39344128.
- PMID 10906521.
- ^ a b "Branchio Oculo Facial Syndrome". National Organization for Rare Disorders (NORD). Retrieved 25 March 2019.